Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse

Vaccine

Volumn 24, Issue 19, 2006, Pages 4144-4151

  Flock, M ^a   Karlström, Å ^c   Lannergard J ^c   Guss, B ^c   Flock, J I ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Extra cellular proteins; Strangles; Streptococcus equi; Vaccination

Indexed keywords

ALPHA 2 MACROGLOBULIN ALBUMIN IMMUNOGLOBULIN G BINDING PROTEIN; ANTIBODY; BACTERIAL PROTEIN; COLLAGEN BINDING PROTEIN; COLLAGEN LIKE PROTEIN; FIBRONECTIN BINDING PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; HORSE DISEASE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; STRANGLES; STREPTOCOCCUS EQUI; STREPTOCOCCUS INFECTION; VACCINATION; WEIGHT REDUCTION;

ANIMALS; ANTIGENS, BACTERIAL; BASE SEQUENCE; COLLAGEN; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; HORSE DISEASES; HORSES; MICE; RECOMBINANT PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS EQUI; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 33646150886     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.016     Document Type: Article

References (22)

1. Harrington D.J., Sutcliffe I.C., and Chanter N. The molecular basis of Streptococcus equi infection and disease. Microbes Infect 4 (2002) 501-510
2. Sweeney C.R., Timoney J.F., Newton J.R., and Hines M.T. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J Vet Intern Med 19 l (2005) 123-134
3. Timoney J.F. The pathogenic equine streptococci. Vet Res 35 4 (2004) 397-409
4. Hamlen H.J., Timoney J.F., and Bell R.J. Epidemiologic and immunologic characteristics of Streptococcus equi infection in foals. JAVMA 204 (1994) 768-775
5. Nally J.E., Artiushin S., Sheoran A.S., Burns P.J., Simon B., Gilley R.M., et al. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system. Vaccine 19 4-5 (2001) 492-497
6. Sheoran A.S., Sponseller B.T., Holmes M.A., and Timoney J.F. Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses. Vet Immunol Immunopathol 59 3-4 (1997) 239-251
7. Sheoran A.S., Artiushin S., and Timoney J.F. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin. Vaccine 20 11-12 (2002) 1653-1659
8. Walker J.A., and Timoney J.F. Construction of a stable non-mucoid deletion mutant of the Streptococcus equi Pinnacle vaccine strain. Vet Microbiol 89 4 (2002) 311-321
9. Jacobs A.A., Goovaerts D., Nuijten P.J., Theelen R.P., Hartford O.M., and Foster T.J. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi. Vet Rec 147 20 (2000) 563-567
10. Newton R., Waller A., and King A. Investigation of suspected adverse reactions following strangles vaccination in horses. Vet Rec 156 9 (2005) 291-292
11. Nilsson I.M., Patti J.T.B., Hook M., and Tarkowski A. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus mediated septic death. J Clin Invest 101 (1998) 2640-2649
12. Rennermalm A., Li Y.-H., Bohaufs L., Jarstrand C., Brauner A., Brennan F.R., et al. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 19 (2001) 3376-3383
13. Josefsson E., Hartford O.M., O'Brien L., Patti J., and Foster T.J. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184 (2001) 1572-1580
14. Flock J.-I. Extracellular matrix binding proteins as targets for the prevention of Staphylococcus aureus infections. Mol Med Today 5 (1999) 532-537
15. Jonsson H., Lindmark H., and Guss B. A protein G-related cell surface protein in Streptococcus zooepidemicus. Infect Immun 63 8 (1995) 2968-2975
16. Lindmark H., and Guss B. SFS, a novel fibronectin-binding protein from Streptococcus equi, inhibits the binding between fibronectin and collagen. Infect Immun 67 5 (1999) 2383-2388
17. Lindmark H., Nilsson M., and Guss B. Comparison of the fibronectin-binding protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference. Infect Immun 69 5 (2001) 3159-3163
18. Flock M., Jacobsson K., Frykberg L., Hirst T.R., Franklin A., Guss B., et al. Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses. Infect Immun 72 (2004) 3228-3236
19. Lannergard J., Frykberg L., and Guss B. CNE, a collagen-binding protein of Streptococcus equi. FEMS Microbiol Lett 16 (2003) 69-74
20. Karlström A., Jacobsson K., Flock M., Flock J.-I., and Guss B. Identification of a novel collagen-like protein, SclC, in Streptococcus equi using signal sequence phage display. Vet Microbiol 104 (2004) 179-188
21. Lannergård J., Flock M., Johansson S., Flock J.-I., and Guss B. Studies of fibronectin-binding proteins of Streptococcus equi. Infect Immun 73 (2005) 7243-7251
22. Chanter N., Smith K.C., and Mumford J.A. Equine strangles modelled in mice. Vet Microbiol 43 (1995) 209-218